Do {beta}2-agonists inhibit capsaicin-induced cough?

00:25 EDT 20th October 2014 | BioPortfolio

Summary of "Do {beta}2-agonists inhibit capsaicin-induced cough?"

No Summary Available

Affiliation

Respiratory Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa City, Ishikawa 920-8641, Japan. E-mail: nori@med3.m.kanazawau.ac.jp.

Journal Details

This article was published in the following journal.

Name: The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology
ISSN: 1399-3003
Pages: 459-60

Links

PubMed Articles [12272 Associated PubMed Articles listed on BioPortfolio]

DECREASED COUGH SENSITIVITY AND ASPIRATION IN PARKINSON'S DISEASE.

Background:Aspiration pneumonia is a leading cause of death in persons with Parkinson's disease (PD). The pathogenesis of these infections is largely attributed to the presence of dysphagia with silen...

Symptomatic treatment of the cough in whooping cough.

Around 16 million cases of whooping cough (pertussis) occur worldwide each year, mostly in low-income countries. Much of the morbidity of whooping cough in children and adults is due to the effects of...

Pharmacodynamics of TRPV1 Agonists in a Bioassay Using Human PC-3 Cells.

Purpose. TRPV1 is a multimodal channel mainly expressed in sensory neurons. We aimed to explore the pharmacodynamics of the TRPV1 agonists, capsaicin, natural capsaicinoids, and piperine in an in vitr...

Beta-agonist-mediated relaxation of airway smooth muscle is PKA-dependent.

Inhaled beta-agonists are effective at reversing bronchoconstriction in asthma, but the mechanism by which they exert this effect is unclear and controversial. PKA is the historically accepted effecto...

Capsaicin-Induced Cardioprotection. Is Hypothermia or the Salvage Kinase Pathway Involved?

Topical capsaicin application was shown to reduce infarct size in experimental animal models. We hypothesized that cardioprotective properties of topical capsaicin application could be related to its ...

Clinical Trials [2073 Associated Clinical Trials listed on BioPortfolio]

Capsaicin Cough Threshold in Chronic Cough Due to Postnasal Drip

This study is being done to find out why some people with mucus dripping down the back of their throat have a nagging cough while others do not cough.

Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888AM1)(COMPLETED)

This is a randomized, double-blind, placebo-controlled, crossover, single center study of SCH 619734 in subjects with chronic cough from an unknown cause. Subjects will be randomized to r...

A Phase II Clinical Study of PDC-748 in Patients With Acute Cough

The pharmacological effects of PDC-748 were tested in numerous in vitro and in vivo studies. The existing pharmacologic findings suggest that PDC-748 possesses certain inhibitory activity ...

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

The purpose of this study is to determine the effectiveness of XEN-D0501 over placebo in reducing the daytime cough frequency in patients with chronic obstructive pulmonary disease (COPD)....

Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests

Cough is a common, disruptive and at times disabling symptom which often prompts patients to seek medical attention. Determining the cause(s) of chronic cough can be challenging, and cost...

Medical and Biotech [MESH] Definitions

Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy.

Drugs that selectively bind to and activate beta-adrenergic receptors.

Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.

Search BioPortfolio:
Loading
Advertisement
Advertisement